Show simple item record

dc.creatorHilton, Taylor
dc.creatorDeCrescenzo, Andrew
dc.creatorMenter, Alan
dc.creatorChavala, Sai H.
dc.date.accessioned2021-01-19T19:19:33Z
dc.date.available2021-01-19T19:19:33Z
dc.date.issued2020-09-01
dc.identifier.urihttps://doi.org/10.1016/j.jdcr.2020.07.015
dc.identifier.urihttps://repository.tcu.edu/handle/116099117/43088
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S2352512620305063
dc.description.abstractCentral serous chorioretinopathy (CSCR) is a condition defined by subretinal fluid accumulation in the area of the macula leading to serous detachment. CSCR is a significant vision-threatening retinopathy that can lead to irreversible vision loss. Although presentation can vary, the classic case comprises unilateral vision loss with the patient reporting a dark spot in the center of their visual field. Corticosteroid use has long been considered to be a factor contributing to CSCR in patients, with oral administration having the most common occurrence. However, there have been previous cases reported of CSCR presenting following topical dermal steroid use. We report a case of a patient with two separate episodes of CSCR induced by use of topical steroids.
dc.language.isoen_USen_US
dc.publisherElsevier
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceJAAD Case Reports
dc.subjectcentral serous chorioretinopathy
dc.subjectpsoriasis
dc.subjectsteroid
dc.titleTopical dermal steroideinduced retinopathy
dc.typeArticle
dc.rights.holder2020 American Academy of Dermatology
dc.rights.licenseCC BY-NC-ND 4.0
local.collegeBurnett School of Medicine
local.departmentBurnett School of Medicine
local.personsChavala (SOM)


Files in this item

Thumbnail
This item appears in the following Collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc-nd/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/